Market Maker Surveillance Report. TRMS, TSPT, ATRN, AUTH, OREX, ORS, Winning Stocks With Lowest Price Friction For Tuesday, Se
September 20, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4019 companies with "abnormal" market making, 2140 companies with positive Friction Factors and 4062 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Tuesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. TRIMERIS INC (NASDAQ:TRMS), TRANSCEPT PHARMACEUTICALS IN (NASDAQ:TSPT), ATRINSIC INC (NASDAQ:ATRN), AUTHENTEC INC (NASDAQ:AUTH), OREXIGEN THERAPEUTICS INC (NASDAQ:OREX), ORSUS XELENT TECHNOLOGIES IN (AMEX:ORS). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Market Maker Friction Factor is shown in the chart below:
Symbol Change Percent Buy Volume Buy %% Sell Volume Sell %% Net Volume Friction TRMS $0.370 18.97% 659,426 55.98% 518,643 44.02% 140,783 3,805 TSPT $1.380 24.51% 1,809,940 54.62% 1,479,074 44.63% 330,866 2,398 ATRN $0.890 39.56% 840,932 49.54% 825,042 48.61% 15,890 179 AUTH $0.570 16.81% 808,912 60.66% 517,399 38.80% 291,513 5,114 OREX $0.960 65.31% 337,952 50.98% 318,019 47.97% 19,933 208 ORS $0.280 23.93% 56,393 46.96% 27,993 23.31% 28,400 1,014Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.
For example, the chart above shows TRMS with a dollar gain Tuesday of $0.37000 and a Friction Factor of 3,805 shares. That means that it only took 3,805 more shares of buying than selling to move TRMS higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.
TRIMERIS INC (NASDAQ:TRMS) - Trimeris, Inc., a biopharmaceutical company, engages primarily in the commercialization of a class of fusion inhibitors for antiviral drug treatments. The companys fusion inhibitors prevent viral fusion, a complex process by which viruses attach to, penetrate, and infect host cells. It offers FUZEON, a human immunodeficiency virus (HIV) fusion inhibitor and a 36-amino acid synthetic peptide that binds to a key region of an HIV surface protein called gp41 under a collaboration with F. Hoffmann-La Roche Ltd. The companys FUZEON inhibitor blocks HIV viral fusion by interfering with certain structural rearrangements within gp41 that are required for HIV to fuse to and enter a host cell. It also holds TRI-1144, a next generation fusion inhibitor candidate that completed Phase I clinical trials. The company was founded in 1993 and is based in Durham, North Carolina.
TRANSCEPT PHARMACEUTICALS IN (NASDAQ:TSPT) - Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of proprietary products that address therapeutic needs in neuroscience. Its principal product includes Intermezzo, a sublingual low dose formulation of zolpidem that is being developed as a sleep aid for use in the middle of the night at the time a patient awakens and has difficulty returning to sleep. The company has collaboration agreement with Purdue Pharmaceutical Products L.P. to commercialize Intermezzo in the United States. Transcept Pharmaceuticals, Inc. is headquartered in Point Richmond, California.
ATRINSIC INC (NASDAQ:ATRN) - Atrinsic, Inc. operates as a direct to consumer Internet marketing company. The company sells entertainment and lifestyle subscription products direct to consumers through the Internet. It offers Kazaa, a subscription-based digital music service that enables users to download music files and ringtones; GatorArcade, a casual game subscription service that provides access to digital games, arcade games, strategy games, puzzles, and mobile entertainment; and subscription-based lifestyle services and clubs, which offer consumers an access to shopping and entertainment coupons and other services that could be redeemed online. The company also develops and manages search engine marketing campaigns for third party advertising clients, as well as offers online marketing services, including a display media platform, online and business intelligence, and brand protection. In addition, it enables advertisers to use its affiliate network to create partnerships with publishers to drive Website traffic, customer acquisitions, and online sales. Further, the company provides lead generation services. It serves corporate clients, advertisers, and end user consumers. The company was formerly known as New Motion, Inc. and changed its name to Atrinsic, Inc. in June 2009. Atrinsic, Inc. was founded in 2005 and is headquartered in New York, New York.
AUTHENTEC INC (NASDAQ:AUTH) - AuthenTec, Inc. provides security, identity management, and touch control technologies for PC, wireless device, and information technology markets primarily in the Asia Pacific, Japan, the United States, Canada, and Europe. The company designs, develops, and sells mixed-signal fingerprint sensor semiconductors that enable users to access and control multiple functions on an electronic device by touching or sliding their finger across the sensor. Its products are used in various applications related to security, password replacement, financial transaction authentication, and personalization applications in a range of PC products and related peripherals, including laptops, desktops, memory keys, hard drives, keyboards, mice, and other devices; wireless devices, such as mobile phones, PDAs, and personal navigation devices; and access control devices that include door locks, time and attendance devices, and remote wireless entry keys. The company primarily sells its products to original equipment manufacturers, original design manufacturers, and contract manufacturers directly, as well as through a network of independent sales representatives and distributors. AuthenTec, Inc. was founded in 1998 and is headquartered in Melbourne, Florida.
OREXIGEN THERAPEUTICS INC (NASDAQ:OREX) - Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its lead combination product candidates include Contrave, which has completed Phase III clinical trials; and Empatic that has completed Phase II clinical trials. Contrave is a combination of two drugs, bupropion and naltrexone, in a sustained release formulation (SR). Bupropion is an antidepressant and smoking cessation medication; naltrexone is a treatment for alcohol and opioid addiction. The companys Empatic product candidate is a combination of bupropion SR and zonisamide SR. Zonisamide, in an immediate release formulation for the adjunctive treatment of partial seizures, a form of epilepsy. The company was founded in 2002 and is based in La Jolla, California.
ORSUS XELENT TECHNOLOGIES IN (AMEX:ORS) - Orsus Xelent Technologies, Inc., together with its subsidiaries, engages in the design, manufacture, and distribution of cellular phones for retail and wholesale distribution in the Peoples Republic of China. It offers cell phones for global system for mobile communications (GSM) and code division multiple access (CDMA) platforms. The company distributes its products through national sales distributors and dealers. It has strategic partnerships with CEC Mobile Co., Ltd., Beijing Xingwang Shidai Tech & Trading Co., Ltd., and CECT-Chinacom Communications Co., Ltd. The company was formerly Universal Flirts Corp. and changed its name to Orsus Xelent Technologies, Inc. in April 2005. Orsus Xelent Technologies, Inc. was founded in 2004 and is headquartered in Beijing, the People's Republic of China.
About BUYINS.NET
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING
SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.
Contact:
BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net